{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:13:35Z","timestamp":1771028015993,"version":"3.50.1"},"reference-count":39,"publisher":"The Endocrine Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,4,1]]},"abstract":"<jats:p>All would agree that hypercalcemia occurs among patients with humoral hypercalcemia of malignancy (HHM) as a result of osteoclastic bone resorption. Some studies suggest that enhanced renal calcium reabsorption, which plays an important pathophysiological role in the hypercalcemia occurring in primary hyperparathyroidism, is also important pathophysiologically in HHM. Other studies have not agreed. In large part, these differences result from the inability to accurately assess creatinine and calcium clearance in critically ill subjects with HHM. To circumvent these issues, we have developed steady state 48-h PTH-related protein (PTHrP) infusion and 8-h hypercalcemic calcium clamp protocols. These techniques allow assessment of the effects of steady state PTHrP and calcium infusions in normal healthy volunteers in a setting in which renal function is stable and measurable and in which the filtered load of calcium can be matched in PTHrP- and calcium-infused subjects.<\/jats:p><jats:p>Normal subjects were infused with saline (placebo), PTHrP, or calcium. Subjects receiving PTHrP, as expected, displayed mild hypercalcemia (10.2 mg\/dL), suppression of endogenous PTH-(1\u201384), and phosphaturia. Subjects receiving the hypercalcemic calcium clamp displayed indistinguishable degrees of hypercalcemia and PTH suppression. Despite their matched degrees of hypercalcemia and PTH suppression, the two groups differed importantly with regard to fractional calcium excretion (FECa). The hypercalcemic calcium clamp group was markedly hypercalciuric (FECa averaged 6.5%), whereas FECa in the PTHrP-infused subjects was approximately 50% lower (between 2.5\u20133.7%), and no different from that in the normal controls, which ranged from 1.5\u20133.0%.<\/jats:p><jats:p>These studies demonstrate that PTHrP is able to stimulate renal calcium reabsorption in healthy volunteers. These studies suggest that PTHrP-induced renal calcium reabsorption, in concert with the well established acceleration of osteoclastic bone resorption, contributes in a significant way to the hypercalcemia observed in patients with HHM.<\/jats:p>","DOI":"10.1210\/jcem.86.4.7406","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:16Z","timestamp":1389200776000},"page":"1525-1531","source":"Crossref","is-referenced-by-count":5,"title":["Parathyroid Hormone-Related Protein-(1\u201336) Stimulates Renal Tubular Calcium Reabsorption in Normal Human Volunteers: Implications for the Pathogenesis of Humoral Hypercalcemia of Malignancy1"],"prefix":"10.1210","volume":"86","author":[{"given":"Mushtaq A.","family":"Syed","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine (M.A.S., M.J.H., M.B.T., A.G.-O., A.F.S.), Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara J.","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine (M.A.S., M.J.H., M.B.T., A.G.-O., A.F.S.), Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Tedesco","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine (M.A.S., M.J.H., M.B.T., A.G.-O., A.F.S.), Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Garcia-Ocan\u0303a","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine (M.A.S., M.J.H., M.B.T., A.G.-O., A.F.S.), Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Wisniewski","sequence":"additional","affiliation":[{"name":"the Graduate School of Public Health, University of Pittsburgh (S.R.W.), Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew F.","family":"Stewart","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, University of Pittsburgh School of Medicine (M.A.S., M.J.H., M.B.T., A.G.-O., A.F.S.), Pittsburgh, Pennsylvania 15213"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071617560183700_R1","first-page":"129","article-title":"Die bedeutung der calciumbestimmung im blute fur die diagnose der niereninsuffzientz.","volume":"99","author":"Zondek","year":"1923","journal-title":"Z Klin Med"},{"key":"2020071617560183700_R2","first-page":"789","article-title":"Case records of the Massachusetts General Hospital (case 27461).","volume":"225","year":"1941","journal-title":"N Engl J Med"},{"key":"2020071617560183700_R3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198012113032401","article-title":"Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and non-humoral groups.","volume":"303","author":"Stewart","year":"1980","journal-title":"N Engl J Med"},{"key":"2020071617560183700_R4","first-page":"705","volume":"40","author":"Godsall","year":"1986"},{"key":"2020071617560183700_R5","first-page":"607","article-title":"Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia.","volume":"81","author":"Nakayama","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem-64-1-175","volume":"64","author":"Yamamoto","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R7","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1210\/jcem.84.10.6026","article-title":"Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.","volume":"84","author":"Rizzoli","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R8","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199004193221603","article-title":"Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of malignancy.","volume":"322","author":"Burtis","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071617560183700_R9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI113358","volume":"81","author":"Stewart","journal-title":"J Clin Invest"},{"key":"2020071617560183700_R10","first-page":"199","article-title":"Parathyroid hormone-related protein(1\u201336) is equipotent with parathyroid hormone(1\u201334) in humans.","volume":"81","author":"Everhart-Caye","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R11","first-page":"900","article-title":"Parathyroid hormone-related protein(1\u201336) is biologically active when administered subcutaneously to humans.","volume":"82","author":"Henry","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R12","first-page":"417","article-title":"A comparison of the in vivo biological responses to exogenous parathyrid hormone-(1\u201334) [PTH-(1\u201334)] and PTH-related peptide-(1\u201334) in man.","volume":"75","author":"Fraher","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jcem-55-2-219","volume":"55","author":"Stewart","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.5650100108","article-title":"In vivo evidence for progressive activation of parathyroid hormone-related peptide gene transcription with tumor growth and stimulation of osteoblastic bone formation at an early stage of humoral hypercalcemia of cancer.","volume":"10","author":"Yamato","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2020071617560183700_R15","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1210\/endo-115-6-2384","article-title":"Development and characterization of a murine squamous carcinoma model of humoral hypercalcemia of malignancy.","volume":"115","author":"Gkonos","year":"1984","journal-title":"Endocrinology"},{"key":"2020071617560183700_R16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1210\/endo-114-3-888","article-title":"Biochemical and histomorphometric characterization of a rat model for humoral hypercalcemia of malignancy.","volume":"114","author":"Insogna","year":"1984","journal-title":"Endocrinology"},{"key":"2020071617560183700_R17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/347388a0","article-title":"Activation of latent Ca2+ channels in renal epithelial cells by parathyroid hormone.","volume":"347","author":"Bacskai","year":"1990","journal-title":"Nature"},{"key":"2020071617560183700_R18"},{"key":"2020071617560183700_R19","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1056\/NEJM197512182932502","article-title":"Prostaglandins as mediators of hypercalcemia associatedl with certain types of cancer.","volume":"293","author":"Seyberth","year":"1975","journal-title":"N Engl J Med"},{"key":"2020071617560183700_R20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/cs0660187","article-title":"Hypercalcaemia of malignancy: evidence for a non-parathyroid humoral agent with an effect on renal tubular handling of calcium.","volume":"66","author":"Ralston","year":"1984","journal-title":"Clin Sci"},{"key":"2020071617560183700_R21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/8756-3282(88)90001-4","article-title":"Bone and renal components in hypercalcemia of malignancy and response to a single infusion of clodronate.","volume":"9","author":"Bonjour","year":"1988","journal-title":"Bone"},{"key":"2020071617560183700_R22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/8756-3282(91)90055-N","article-title":"Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and non-malignant hypercalcemia.","volume":"12","author":"Buchs","year":"1991","journal-title":"Bone"},{"key":"2020071617560183700_R23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jbmr.5650040115","article-title":"Contrasting mechanisms of hypercalcemia in patients with early and advanced humoral hypercalcemia of malignancy.","volume":"4","author":"Ralston","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2020071617560183700_R24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0140-6736(69)90813-7","article-title":"Role of kidney in regulation of plasma calcium.","volume":"2","author":"Nordin","year":"1969","journal-title":"Lancet"},{"key":"2020071617560183700_R25","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1210\/endo-119-3-1004","article-title":"Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by leydig cell tumor in thyroparathyroidectomized rats.","volume":"119","author":"Rizzoli","year":"1986","journal-title":"Endocrinology"},{"key":"2020071617560183700_R26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jbmr.5650030512","article-title":"Increased renal calcium reabsorption in an animal model of hypercalcemia of human malignancy.","volume":"3","author":"Shipley","year":"1988","journal-title":"J Bone Miner Res"},{"key":"2020071617560183700_R27","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.3685994","article-title":"Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro.","volume":"238","author":"Horiuchi","year":"1987","journal-title":"Science"},{"key":"2020071617560183700_R28","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1172\/JCI113406","article-title":"Effects of a synthetic peptide of PTH-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents in rodents.","volume":"81","author":"Yates","year":"1988","journal-title":"J Clin Invest"},{"key":"2020071617560183700_R29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jbmr.5650050615","article-title":"Direct effects of synthetic parathyroid hormone-like peptides on renal calcium transport.","volume":"5","author":"Scheinman","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2020071617560183700_R30","first-page":"81","article-title":"Role of 1,25-(OH)2D in the hypercalcemia associated with the Walker carcinosarcoma in rats.","volume":"17","author":"Traba","year":"1989","journal-title":"Med Sci Res"},{"key":"2020071617560183700_R31","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0024-3205(82)90237-5","article-title":"Hypercalcemia in association with a leydig cell tumor in the rat: a model for tumor-induced hypercalcemia in man.","volume":"30","author":"Berger","year":"1982","journal-title":"Life Sci"},{"key":"2020071617560183700_R32","first-page":"E309","article-title":"Effect of hypercalcemia-producing tumor on 1,25-(OH)2D3 biosynthesis in athymic mice","volume":"256","author":"Kukreja","year":"1989","journal-title":"Am J Physiol."},{"key":"2020071617560183700_R33","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1210\/endo-124-5-2057","article-title":"Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production.","volume":"124","author":"Fukumoto","year":"1989","journal-title":"Endocrinology"},{"key":"2020071617560183700_R34","first-page":"E297","article-title":"Effect of parathyroid hormone-like peptides on 25-hydroxyvitamin D-1-\u03b1-hydroxylase activity in rodents","volume":"258","author":"Walker","year":"1990","journal-title":"Am J Physiol."},{"key":"2020071617560183700_R35","first-page":"364","article-title":"Evaluation of the calcium-PTH axis and renal calcium handling of phosphate by calcium and citrate clamp techniques in normal subjects and in patients with heavy proteinuria.","volume":"48","author":"Saha","year":"1997","journal-title":"Clin Nephrol"},{"key":"2020071617560183700_R36","first-page":"715","article-title":"Calcium infusion suggests a set-point abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.","volume":"76","author":"Khosla","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071617560183700_R37","first-page":"457","volume":"52","author":"Sorensen","year":"1992"},{"key":"2020071617560183700_R38","doi-asserted-by":"crossref","first-page":"24371","DOI":"10.1074\/jbc.271.40.24371","article-title":"Structural and physiologic characterization of the mid-region secretory form of PTHrP.","volume":"271","author":"Wu","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071617560183700_R39","first-page":"317","article-title":"A high-abundance mid-region species of parathyroid hormone-related protein: immunologic and chromatographic characterization in plasma.","volume":"78","author":"Burtis","year":"1994","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/4\/1525\/9165097\/jcem1525.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/86\/4\/1525\/9165097\/jcem1525.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T11:58:29Z","timestamp":1746100709000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/86\/4\/1525\/2848308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.86.4.7406","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,1]]}}}